Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Grégory Behar
CEO | Chief Executive Officer | 55 | 01/01 |
Director of Finance/CFO | - | 03/04/23 | |
Ulrike Lemke
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Luc Burgard
COO | Chief Operating Officer | 43 | - |
Marc Funk
BRD | Director/Board Member | 64 | 01/01/21 |
Human Resources Officer | - | - | |
Kieran Chouhan
PRN | Corporate Officer/Principal | - | 01/02/19 |
Bernard Pluta
PRN | Corporate Officer/Principal | - | 01/10/15 |
Shabbir Mostafa
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 60 | 01/06/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Steven Klosk
BRD | Director/Board Member | 67 | 01/03/21 |
Director/Board Member | 67 | 01/01/21 | |
Richard Ridinger
CHM | Chairman | 66 | 01/03/21 |
Marc Funk
BRD | Director/Board Member | 64 | 01/01/21 |
Director/Board Member | 43 | 01/03/21 | |
Henrik Giver
BRD | Director/Board Member | 35 | 01/01/21 |
Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 370 000 | 0 | 0 | 56,25 % |
Acción B | 10 | 21 312 000 | 0 | 0 | |
Acción C | 1 | 79 803 683 | 57 089 305 ( 71,54 %) | 0 |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Recipharm Ltd.
Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. |
Pharmaceuticals: Major
|
Recipharm Holdings Ltd.
Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. |
Miscellaneous
|
Recipharm Venture Fund AB
Recipharm Venture Fund AB Investment ManagersFinance Recipharm Venture Fund AB is a venture capital fund that makes strategic investments in start-ups and biotechnology companies that are seen as important to Recipharm's business. The fund invests in both private and public companies. |
Investment Managers
|
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+5,48 % | 69,91 mil M | |
+12,55 % | 9242,18 M | |
-13,75 % | 5046,24 M | |
+42,38 % | 4467,71 M | |
+4,51 % | 3916,61 M | |
-19,05 % | 2412,47 M | |
-28,72 % | 2232,64 M | |
+11,13 % | 2015,8 M | |
+6,53 % | 1664,06 M |